Home › United Therapeutics submits pre-market approval application for use...
 

Keywords :   


United Therapeutics submits pre-market approval application for use...

2014-12-26 10:50:53| Biotech - Topix.net

United Therapeutics Corporation announced today that Medtronic, Inc. has submitted a pre-market approval application to the U.S. Food and Drug Administration for the use of Medtronic's SynchroMedA II implantable drug infusion system for use with United Therapeutics' RemodulinA Injection delivered intravenously to patients with pulmonary arterial hypertension.

Tags: use united application approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »